Concerns that the tobacco quitting drug varenicline (Champix) is associated with an increased risk of suicidality and accidents have not been supported by a large observational study. Researchers from Sweden and Oxford in the UK looked at the records of over 69,000 individuals in Sweden who were prescribed varenicline between 2006 and 2009. They found no ...
Already a member?
Enter your email to keep reading.